Johnson & Johnson Return on Investment 1986-2025 | JNJ
Current and historical return on investment (ROI) values for Johnson & Johnson (JNJ) over the last 10 years.
| Johnson & Johnson ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2025-09-30 |
$31.50B |
|
37.47% |
| 2025-06-30 |
$27.35B |
$117.71B |
24.99% |
| 2025-03-31 |
$26.60B |
$116.46B |
25.14% |
| 2024-12-31 |
$16.69B |
$102.14B |
16.61% |
| 2024-09-30 |
$17.63B |
$101.45B |
17.88% |
| 2024-06-30 |
$19.51B |
$103.17B |
19.99% |
| 2024-03-31 |
$20.06B |
$95.10B |
20.20% |
| 2023-12-31 |
$15.06B |
$94.66B |
14.77% |
| 2023-09-30 |
$12.72B |
$97.28B |
12.20% |
| 2023-06-30 |
$12.68B |
$110.31B |
12.02% |
| 2023-03-31 |
$12.21B |
$105.80B |
11.73% |
| 2022-12-31 |
$19.36B |
$103.69B |
18.70% |
| 2022-09-30 |
$18.11B |
$102.20B |
17.48% |
| 2022-06-30 |
$16.79B |
$104.65B |
16.28% |
| 2022-03-31 |
$17.61B |
$103.56B |
17.27% |
| 2021-12-31 |
$19.18B |
$104.01B |
19.16% |
| 2021-09-30 |
$19.59B |
$100.40B |
19.97% |
| 2021-06-30 |
$20.14B |
$99.89B |
20.71% |
| 2021-03-31 |
$17.42B |
$96.10B |
18.47% |
| 2020-12-31 |
$16.50B |
$95.91B |
17.94% |
| 2020-09-30 |
$19.07B |
$97.15B |
21.31% |
| 2020-06-30 |
$16.31B |
$88.04B |
18.87% |
| 2020-03-31 |
$19.42B |
$86.69B |
22.43% |
| 2019-12-31 |
$17.33B |
$85.97B |
20.02% |
| 2019-09-30 |
$16.23B |
$85.13B |
18.68% |
| 2019-06-30 |
$19.01B |
$88.48B |
21.32% |
| 2019-03-31 |
$16.94B |
$86.62B |
18.80% |
| 2018-12-31 |
$18.00B |
$87.44B |
19.62% |
| 2018-09-30 |
$17.44B |
$94.11B |
18.83% |
| 2018-06-30 |
$17.80B |
$92.29B |
18.90% |
| 2018-03-31 |
$17.58B |
$93.09B |
18.32% |
| 2017-12-31 |
$17.67B |
$90.84B |
18.21% |
| 2017-09-30 |
$19.44B |
$100.65B |
19.93% |
| 2017-06-30 |
$19.93B |
$99.29B |
20.66% |
| 2017-03-31 |
$20.08B |
$97.36B |
20.95% |
| 2016-12-31 |
$19.80B |
$92.86B |
20.90% |
| 2016-09-30 |
$19.24B |
$96.32B |
20.78% |
| 2016-06-30 |
$18.08B |
$97.01B |
20.11% |
| 2016-03-31 |
$18.92B |
$92.88B |
21.76% |
| 2015-12-31 |
$19.20B |
$84.01B |
22.74% |
| 2015-09-30 |
$18.14B |
$85.63B |
21.43% |
| 2015-06-30 |
$20.83B |
$85.22B |
24.32% |
| 2015-03-31 |
$20.71B |
$82.82B |
23.76% |
| 2014-12-31 |
$20.56B |
$84.87B |
23.11% |
| 2014-09-30 |
$20.61B |
$89.74B |
23.00% |
| 2014-06-30 |
$17.47B |
$91.35B |
20.06% |
| 2014-03-31 |
$16.63B |
$89.93B |
19.79% |
| 2013-12-31 |
$15.47B |
$87.38B |
19.07% |
| 2013-09-30 |
$15.82B |
$79.55B |
20.19% |
| 2013-06-30 |
$15.75B |
$79.31B |
20.39% |
| 2013-03-31 |
$12.99B |
$78.22B |
17.22% |
| 2012-12-31 |
$13.78B |
$76.32B |
18.50% |
| 2012-09-30 |
$10.99B |
$75.19B |
15.08% |
| 2012-06-30 |
$11.51B |
$71.96B |
15.82% |
| 2012-03-31 |
$12.90B |
$74.38B |
17.50% |
| 2011-12-31 |
$12.36B |
$70.05B |
17.08% |
| 2011-09-30 |
$14.27B |
$74.56B |
20.01% |
| 2011-06-30 |
$14.38B |
$75.81B |
20.75% |
| 2011-03-31 |
$15.18B |
$69.12B |
23.16% |
| 2010-12-31 |
$16.95B |
$65.74B |
26.69% |
| 2010-09-30 |
$17.32B |
$66.47B |
28.05% |
| 2010-06-30 |
$17.35B |
$60.79B |
29.01% |
| 2010-03-31 |
$17.39B |
$60.97B |
29.88% |
| 2009-12-31 |
$15.76B |
$58.81B |
28.17% |
| 2009-09-30 |
$16.67B |
$58.64B |
30.93% |
| 2009-06-30 |
$16.71B |
$54.43B |
31.68% |
| 2009-03-31 |
$16.83B |
$51.84B |
31.77% |
| 2008-12-31 |
$16.93B |
$50.63B |
31.83% |
| 2008-09-30 |
$15.74B |
$54.13B |
29.63% |
| 2008-06-30 |
$14.72B |
$55.21B |
28.50% |
| 2008-03-31 |
$14.38B |
$52.79B |
29.26% |
| 2007-12-31 |
$13.28B |
$50.39B |
28.46% |
| 2007-09-30 |
$13.66B |
$48.21B |
30.76% |
| 2007-06-30 |
$14.05B |
$45.14B |
32.68% |
| 2007-03-31 |
$13.62B |
$42.94B |
32.14% |
| 2006-12-31 |
$14.59B |
$41.33B |
34.38% |
| 2006-09-30 |
$14.38B |
$42.58B |
34.01% |
| 2006-06-30 |
$14.14B |
$42.72B |
34.17% |
| 2006-03-31 |
$13.80B |
$43.10B |
34.44% |
| 2005-12-31 |
$13.12B |
$40.73B |
34.22% |
| 2005-09-30 |
$12.73B |
$38.99B |
34.65% |
| 2005-06-30 |
$12.59B |
$37.50B |
35.34% |
| 2005-03-31 |
$12.75B |
$36.11B |
36.97% |
| 2004-12-31 |
$12.33B |
$34.38B |
37.00% |
| 2004-09-30 |
$12.59B |
$34.47B |
39.10% |
| 2004-06-30 |
$12.26B |
$33.01B |
39.82% |
| 2004-03-31 |
$10.88B |
$31.46B |
36.96% |
| 2003-12-31 |
$10.31B |
$29.82B |
36.70% |
| 2003-09-30 |
$9.78B |
$28.89B |
36.49% |
| 2003-06-30 |
$9.23B |
$27.60B |
35.99% |
| 2003-03-31 |
$9.60B |
$26.04B |
38.80% |
| 2002-12-31 |
$9.29B |
$24.72B |
37.59% |
| 2002-09-30 |
$8.89B |
$24.19B |
35.33% |
| 2002-06-30 |
$8.60B |
$24.02B |
33.62% |
| 2002-03-31 |
$8.30B |
$25.95B |
32.08% |
| 2001-12-31 |
$7.90B |
$26.45B |
31.84% |
| 2001-09-30 |
$7.60B |
$25.92B |
31.56% |
| 2001-06-30 |
$7.33B |
$25.20B |
32.09% |
| 2001-03-31 |
$7.11B |
$21.66B |
32.87% |
| 2000-12-31 |
$6.79B |
$23.56B |
32.14% |
| 2000-09-30 |
$6.36B |
$20.90B |
31.99% |
| 2000-06-30 |
$6.21B |
$20.41B |
32.65% |
| 2000-03-31 |
$6.06B |
$19.59B |
33.84% |
| 1999-12-31 |
$5.93B |
$18.66B |
35.09% |
| 1999-09-30 |
$6.24B |
$17.38B |
39.14% |
| 1999-06-30 |
$5.95B |
$15.95B |
38.76% |
| 1999-03-31 |
$5.62B |
$15.57B |
37.50% |
| 1998-12-31 |
$5.32B |
$14.86B |
36.54% |
| 1998-09-30 |
$5.12B |
$15.06B |
36.01% |
| 1998-06-30 |
$4.90B |
$14.42B |
35.47% |
| 1998-03-31 |
$4.76B |
$13.93B |
35.39% |
| 1997-12-31 |
$4.62B |
$13.49B |
35.30% |
| 1997-09-30 |
$8.68B |
$13.44B |
67.90% |
| 1997-06-30 |
$8.69B |
$12.99B |
69.42% |
| 1997-03-31 |
$4.44B |
$12.47B |
35.91% |
| 1996-12-31 |
$4.30B |
$12.25B |
35.18% |
| 1996-09-30 |
$0.04B |
$12.40B |
0.30% |
| 1996-06-30 |
$-0.21B |
$12.34B |
-1.77% |
| 1996-03-31 |
$3.73B |
$11.94B |
33.26% |
| 1995-12-31 |
$3.51B |
$11.15B |
32.69% |
| 1995-09-30 |
$3.43B |
$11.02B |
33.39% |
| 1995-06-30 |
$3.25B |
$10.70B |
33.86% |
| 1995-03-31 |
$3.04B |
$10.09B |
34.01% |
| 1994-12-31 |
$2.05B |
$9.32B |
24.56% |
| 1994-09-30 |
$1.94B |
$8.25B |
24.95% |
| 1994-06-30 |
$1.78B |
$8.13B |
23.86% |
| 1994-03-31 |
$1.69B |
$7.60B |
23.53% |
| 1993-12-31 |
$2.39B |
$7.06B |
34.13% |
| 1993-09-30 |
$2.35B |
$6.97B |
34.09% |
| 1993-06-30 |
$2.34B |
$7.13B |
33.39% |
| 1993-03-31 |
$2.32B |
$6.90B |
33.32% |
| 1992-12-31 |
$2.28B |
$6.54B |
32.77% |
| 1992-09-30 |
$2.31B |
$7.49B |
32.71% |
| 1992-06-30 |
$2.24B |
$6.97B |
32.73% |
| 1992-03-31 |
$2.18B |
$6.80B |
32.76% |
| 1991-12-31 |
$2.16B |
$6.93B |
33.19% |
| 1991-09-30 |
$2.08B |
$6.68B |
32.73% |
| 1991-06-30 |
$2.03B |
$6.15B |
32.87% |
| 1991-03-31 |
$1.96B |
$6.32B |
32.24% |
| 1990-12-31 |
$1.99B |
$6.22B |
34.02% |
| 1990-09-30 |
$1.98B |
$6.02B |
35.11% |
| 1990-06-30 |
$1.92B |
$5.73B |
35.57% |
| 1990-03-31 |
$1.85B |
$5.45B |
35.61% |
| 1989-12-31 |
$1.66B |
$5.32B |
33.12% |
| 1989-09-30 |
$1.56B |
$5.13B |
32.23% |
| 1989-06-30 |
$1.49B |
$4.82B |
32.17% |
| 1989-03-31 |
$1.46B |
$4.79B |
32.36% |
| 1988-12-31 |
$1.40B |
$4.67B |
31.90% |
| 1988-09-30 |
$1.30B |
$4.21B |
30.31% |
| 1988-06-30 |
$1.30B |
$4.32B |
30.65% |
| 1988-03-31 |
$1.30B |
$4.41B |
32.37% |
| 1987-12-31 |
$1.21B |
$4.22B |
32.37% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$450.090B |
$94.943B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
